Amplifon (AMFPF) Stock Price, News & Analysis

Company Overview

Amplifon S.p.A. is a global leader in hearing care solutions, providing a comprehensive range of products and services designed to improve the quality of life for individuals with hearing loss. Founded in Milan, Italy in 1950, the company has grown from a local hearing aid retailer into an international network of specialized hearing care centers. Amplifon’s core offerings include hearing assessments, personalized device fitting, tinnitus management and after-sales support, ensuring each client receives tailored solutions.

The company’s product portfolio features a wide selection of premium hearing aids and assistive listening devices from leading manufacturers, as well as proprietary technology developed through Amplifon’s research initiatives. In addition to traditional behind-the-ear and in-the-ear devices, Amplifon offers advanced bone conduction systems, cochlear implant partnerships and wireless accessories that integrate with smartphones and home entertainment systems.

Amplifon operates across more than 25 countries, including key markets in Europe, North America, Latin America, Asia-Pacific and the Middle East. Its extensive retail network comprises over 11,000 specialized hearing care centers staffed by audiologists, hearing care experts and trained technicians. This global footprint allows the company to leverage local expertise while sharing best practices, ensuring consistent service quality and access to the latest innovations in auditory care.

Under the leadership of CEO Cristiano Leone and Chairman Andrea Pessina, Amplifon continues to invest in digital health platforms, teleaudiology services and strategic partnerships to enhance patient access and improve outcomes. The company’s commitment to research and professional training has established it as a trusted partner for healthcare providers and a preferred destination for individuals seeking comprehensive hearing solutions.

Key Stats

• Today's Range: $23.85 to $23.85
• 50-Day Range: $19.00 to $23.85
• 52-Week Range: $19.00 to $31.88
• Volume: N/A
• Average Volume: 27 shs
• Market Capitalization: $5.38 billion
• P/E Ratio: 29.44
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Moderate Buy

AMFPF Stock Analysis - Frequently Asked Questions

How have AMFPF shares performed this year?

Amplifon's stock was trading at $26.0025 at the start of the year. Since then, AMFPF shares have decreased by 8.3% and is now trading at $23.85.
View the best growth stocks for 2025 here.

How were Amplifon's earnings last quarter?

Amplifon S.p.A. (OTCMKTS:AMFPF) announced its quarterly earnings results on Thursday, March, 20th. The company reported $0.22 EPS for the quarter, missing analysts' consensus estimates of $0.25 by $0.03. The business earned $687.81 million during the quarter, compared to analysts' expectations of $622.52 million. Amplifon had a net margin of 5.90% and a trailing twelve-month return on equity of 13.68%.

How do I buy shares of Amplifon?

Shares of AMFPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 3/20/2025
• Today: 7/02/2025
• Next Earnings (Estimated): 7/29/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:AMFPF
• CIK: N/A
• Web: corporate.amplifon.com
• Phone: (390) 257-4721
• Fax: N/A
• Employees: 15,070
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $0.68
• Trailing P/E Ratio: 35.07
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $157.31 million
• Net Margins: 5.90%
• Pretax Margin: 8.17%
• Return on Equity: 13.68%
• Return on Assets: 3.97%

Debt

• Debt-to-Equity Ratio: 0.83
• Current Ratio: 0.62
• Quick Ratio: 0.54

Sales & Book Value

• Annual Sales: $2.61 billion
• Price / Sales: 2.06
• Cash Flow: $2.19 per share
• Price / Cash Flow: 10.90
• Book Value: $5.52 per share
• Price / Book: 4.32

Miscellaneous

• Outstanding Shares: 225,500,000
• Free Float: N/A
• Market Cap: $5.38 billion
• Optionable: Not Optionable
• Beta: 0.54